Atherton Lane Advisers’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q4 | $33M | Buy |
275,830
+7,798
| +3% | +$934K | 1.92% | 14 |
|
|
2015
Q3 | $29M | Buy |
268,032
+45,852
| +21% | +$4.96M | 1.81% | 15 |
|
|
2015
Q2 | $25.7M | Buy |
222,180
+6,400
| +3% | +$741K | 1.42% | 25 |
|
|
2015
Q1 | $24.9M | Buy |
215,780
+2,437
| +1% | +$281K | 1.34% | 32 |
|
|
2014
Q4 | $23.9M | Buy |
213,343
+757
| +0.4% | +$84.7K | 1.31% | 33 |
|
|
2014
Q3 | $20.1M | Buy |
212,586
+8,760
| +4% | +$830K | 1.15% | 40 |
|
|
2014
Q2 | $17.5M | Buy |
203,826
+26,104
| +15% | +$2.24M | 0.97% | 53 |
|
|
2014
Q1 | $12.4M | Buy |
177,722
+5,672
| +3% | +$396K | 0.77% | 60 |
|
|
2013
Q4 | $14.5M | Buy |
172,050
+1,130
| +0.7% | +$95.5K | 0.92% | 57 |
|
|
2013
Q3 | $13.2M | Sell |
170,920
-3,050
| -2% | -$235K | 0.9% | 61 |
|
|
2013
Q2 | $10.2M | Buy |
+173,970
| New | +$10.2M | 0.74% | 59 |
|